Quality of life metrics in arrhythmogenic right ventricular cardiomyopathy patients: The impact of age, shock and sex.

[1]  H. Calkins,et al.  Cardiology patient page. Patient's guide to arrhythmogenic right ventricular dysplasia/cardiomyopathy: past to present. , 2014, Circulation.

[2]  S. Pedersen,et al.  Gender Differences in Psychological Distress and Quality of Life in Patients with an ICD 1‐Year Postimplant , 2014, Pacing and clinical electrophysiology : PACE.

[3]  S. Russell,et al.  Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. , 2013, Journal of the American College of Cardiology.

[4]  H. Calkins,et al.  Update on Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C) , 2013, Current Treatment Options in Cardiovascular Medicine.

[5]  S. Sears,et al.  Modern-day patient challenge: manage cardiac disease, accept devices, and minimize distress. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[6]  James A. White,et al.  Myocardial fibrosis and quality of life in patients with non-ischemic cardiomyopathy: a cardiovascular magnetic resonance imaging study , 2013, The International Journal of Cardiovascular Imaging.

[7]  J. Finch,et al.  The Florida Shock Anxiety Scale (FSAS) for Patients with Implantable Cardioverter Defibrillators: Testing Factor Structure, Reliability, and Validity of a Previously Established Measure , 2012, Pacing and clinical electrophysiology : PACE.

[8]  B. Murray Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C): A Review of Molecular and Clinical Literature , 2012, Journal of Genetic Counseling.

[9]  H. Calkins,et al.  General and Disease-Specific Psychosocial Adjustment in Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy With Implantable Cardioverter Defibrillators: A Large Cohort Study , 2012, Circulation. Cardiovascular genetics.

[10]  Emily A. Kuhl,et al.  The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: a systematic review. , 2011, Journal of psychosomatic research.

[11]  S. Sears,et al.  Caring for the Heart and Mind in ICD Patients , 2011 .

[12]  R. Erbel,et al.  Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a review and update , 2011, Clinical Research in Cardiology.

[13]  S. Sears,et al.  Shock and Patient‐Centered Outcomes Research: Is an ICD Shock Still a Critical Event? , 2010, Pacing and clinical electrophysiology : PACE.

[14]  J. Conti,et al.  Female‐Specific Education, Management, and Lifestyle Enhancement for Implantable Cardioverter Defibrillator Patients: The FEMALE‐ICD Study , 2010, Pacing and clinical electrophysiology : PACE.

[15]  J. Denollet,et al.  Somatosensory amplification mediates sex differences in psychological distress among cardioverter-defibrillator patients. , 2010, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[16]  L. Jordaens,et al.  Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Diagnostic Task Force Criteria: Impact of New Task Force Criteria , 2010, Circulation. Arrhythmia and electrophysiology.

[17]  Wojciech Zareba,et al.  Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria , 2010, European heart journal.

[18]  J. Conti,et al.  Effective Management of ICD Patient Psychosocial Issues and Patient Critical Events , 2009, Journal of cardiovascular electrophysiology.

[19]  F. Anselme,et al.  A comparison of anxiety, depression and quality of life between device shock and nonshock groups in implantable cardioverter defibrillator recipients. , 2009, General hospital psychiatry.

[20]  R. Passman,et al.  Implantable cardioverter defibrillators and quality of life: results from the defibrillators in nonischemic cardiomyopathy treatment evaluation study. , 2007, Archives of Internal Medicine.

[21]  Emily A. Kuhl,et al.  Anxiety and Marital Adjustment in Patients With Implantable Cardioverter Defibrillator and Their Spouses , 2007, Journal of cardiopulmonary rehabilitation and prevention.

[22]  J. Conti,et al.  How to Respond to an Implantable Cardioverter-Defibrillator Shock , 2005, Circulation.

[23]  S. Sears,et al.  Measuring Patient Acceptance of Implantable Cardiac Device Therapy: , 2005, Journal of cardiovascular electrophysiology.

[24]  Haomiao Jia,et al.  Mapping the SF-12 to the EuroQol EQ-5D Index in a National US Sample , 2004, Medical decision making : an international journal of the Society for Medical Decision Making.

[25]  J. Ware,et al.  A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. , 1996, Medical care.